Market Insight

Vortex Imaging has raised a $12 million financing round to speed clinical development, approval and commercial launch of its cloud-enabled computational ultrasound platform. This was a vital round for the company, as it moves toward changing how costly advanced 3D diagnostics are used by shifting th

Spineology Inc., a pioneer in patient-specific spinal implants, has announced the release of OptiMesh HA Nano. This groundbreaking development combines Spineology’s expandable implant technology with Promimic AB’s HA Nano Surface, poised to revolutionize spinal fusion surgeries. With its potential t

Epiminder announced the first implantation of its Minder System in the US, a device developed for ongoing monitoring of epilepsy.
The procedure took place at the Perelman School of Medicine at the University of Pennsylvania, marking the site as the initial participant in the diagnosing epilepsy to ef

Robocath announced that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.
The Rouen, France-based company said its second-generation robotic system integrates capabilities designed to meet the increasing demands of complex coronary procedures. I

Biotronik announced the successful first-in-human implantations of its LivIQ leadless pacemaker system.
The implants came in Australia as part of the company’s BIO|CONCEPT.LivIQ study, a premarket clinical investigation designed to evaluate the system’s preliminary safety and performance. Dr. Paul Go

RevealDX has obtained US Food and Drug Administration (FDA) clearance for RevealAI-Lung, an artificial intelligence (AI)-based software for lung nodule risk assessment.
The Washington-based company’s Computer-Assisted Diagnostic (CADx) software is designed to analyse chest CT scans for lung nodules a

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced the publication of a journal article in Pain Physician demonstrating that its HYDRAFIL System for disc augmentation safely generated lasting c

Medtronic, a global leader in healthcare technology, announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated. The intent to acquire CathWorks follows a 2022 strategic partn

CraniUS Therapeutics announced that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass.
NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted drug